Burma: Drug Control Progress and Possibilities
Burma is the second largest opium producer in the world, and is quickly becoming a hotbed of methamphetamine production. Opium profits have helped to finance conflict within Burma for both the central government and the insurgent ethnic groups; however, with the 1989 ceasefire agreements with the insurgent ethnic groups the drug control context changed dramatically. In April 2002, the Kokang and Wa ethnic leaders, whose regions account for the vast majority of opium poppy cultivation, committed to making their territory opium-free by 2003 and July 2005 respectively. The combined drug control efforts of national and local leaders have shown promising results, as both UN and US opium surveys have confirmed large declines in poppy cultivation. As Burma continues to reduce opium cultivation, it has struggled in recent years with an increase in the production of amphetamine-type stimulants (ATS). Combating the threats from opium and ATS will require different strategies. Stronger border controls, improved law enforcement and interdiction techniques must complement development strategies and alternative cropping policies.
To our knowledge, this item is not available for
download. To find whether it is available, there are three
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
Volume (Year): 25 (2006)
Issue (Month): 1 ()
|Contact details of provider:|| Postal: Neuer Jungfernstieg 21, D-20354 Hamburg|
Phone: +49 (0)40 42825-593
Fax: +49 (0)40 42825-547
Web page: http://www.currentsoutheastasianaffairs.org
More information through EDIRC
|Order Information:|| Web: http://www.giga-hamburg.de/suedostasien-aktuell Email: |
When requesting a correction, please mention this item's handle: RePEc:gig:soaktu:v:25:y:2006:i:1:p:7-22. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Marco Bünte)or (Howard Loewen)
If references are entirely missing, you can add them using this form.